Abstract
.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Awad AG, Voruganti LNP. Measuring quality of life in patients with schizophrenia. Pharmacoeconomics. 1997;11:32–47.
Awad AG, Voruganti LNP. Measuring quality of life in schizophrenia: an update. Pharmacoeconomics. 2012;30:183–195.
Baker F, Intagliata J. Quality of life in the evaluation of community support systems. Eval Program Plann. 1982;5:69–79.
Lehman AF. A quality of life interview for the chronically mentally ill. Eval Program Plann. 1988;11:51–62.
Heinrichs DW, Hanlon TE, Carpenter WT. The Quality of Life Scale: an instrument for rating the schizophrenic deficit symptoms. Schizophr Bull. 1984;10:388–398.
Oliver JPJ. How to use quality of life measures in individual care. In: Priebe S, Oliver JPJ, Kaiser W, eds. Quality of Life and Mental Health Care. Petersfield, UK: Wrightson Biomedical Publishing; 1999:81–105.
Nadalet L, Kohl FS, Pringuey D, et al. Validation of a Subjective Quality of Life Questionnaire (S.QUA.LA) in schizophrenia. Schizophr Res. 2005;76:73–81.
Auquier P, Simioni MC, Sapin C, et al. Development and validation of a patient-based health related quality of life questionnaire in schizophrenia: the S-QOL. Schizophr Res. 2003;63:137–149.
Wilkinson G, Hesdon B, Wild D, et al. Self-report quality of life measure for people with schizophrenia: SQLS. Br J Psychiatry. 2000;177:42–46.
Luo N, Seng BK, Xie F, Li SC, Thumboo J. Psychometric evaluation of the Schizophrenia Quality of Life Scale (SQLS) in English- and Chinese-speaking Asians in Singapore. Qual Life Res. 2008;17:115–122.
Ware JE, Sherbourne CD. The MOS 36-Item Short Form Health Status Survey (SF-36). 1. Conceptual framework and item selection. Med Care. 1992;30:MS253–MS265.
Endicott J, Spitzer RL, Fleiss Jl. The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976;33:766–771.
Awad AG. Subjective response to neuroleptics in schizophrenia. Schizophr Bull. 1993;19:609–618.
Voruganti LNP, Awad AG. Personal evaluation of transition in treatment (PETiT): a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia. Schizophr Res. 2002;56:37–46.
Kolotkin RL, Crosby RD, Corey-Lisle PK, et al. Performance of weight-related measure of quality of life in a psychiatric sample. Qual Life Res. 2006;15:587–596.
Awad AG, Voruganti LNP. Body weight, image and self-esteem evaluation questionnaire: development and validation of a new scale. Schizophr Res. 2004;70:63–67.
Awad AG, Voruganti LNP. Antipsychotic medications, schizophrenia and the issue of quality of life. In: Ritsner M, Awad AG (eds). Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders. The Netherlands: Springer; 2007:307–319.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Healthcare, a part of Springer Science+Business Media
About this chapter
Cite this chapter
Awad, G. (2012). Quality of Life Measurements in a Person with Schizophrenia. In: Keefe, R. (eds) Guide to Assessment Scales in Schizophrenia. Springer Healthcare, Heidelberg. https://doi.org/10.1007/978-1-908517-71-5_5
Download citation
DOI: https://doi.org/10.1007/978-1-908517-71-5_5
Published:
Publisher Name: Springer Healthcare, Heidelberg
Print ISBN: 978-1-908517-52-4
Online ISBN: 978-1-908517-71-5
eBook Packages: MedicineMedicine (R0)